Phase 2 study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 (CCL2), in metastatic castration-resistant prostate cancer

著者: Kenneth J. Pienta, Jean-Pascal Machiels, Dirk Schrijvers, B. Yа. Alekseev, М. I. Shkolnik, Simon J. Crabb, Susan Li, Shobha Seetharam, Thomas A. Puchalski, Chris H. Takimoto, Yusri Elsayed, Fitzroy W. Dawkins, Johann S. de Bono - Investigational New Drugs 2012 被引用: 399